CKS2 acts as an oncogene in glioma to promote cell proliferation, invasion and epithelial-mesenchymal transformation pathway, while CKS2 knockdown can inhibit the proliferation, invasion and epithelial-mesenchymal transformation of glioma cell lines (81). This evidence concerns the gene CKS2 and central nervous system cancer.